A new study found a link between SGLT-2 inhibitors and a significantly lower risk of dementia in people with diabetes. Here's ...
One study published in December 2022 found that semaglutide lowered the risk of dementia in patients with type 2 diabetes.
A new study found a link between SGLT-2 inhibitors and a significantly lower risk of dementia in people with diabetes. Here's ...
A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...
A Korean study published recently suggests that people with type 2 diabetes who are prescribed a particular class of drug ...
A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...
Is there anything that Ozempic can't do? Earlier this month, research suggested the appetite-suppressing injection, known as ...
Ozempic and similar weight-loss drugs can lower the risk of heart attack, stroke, kidney and liver disease, and even increase ...
Poor glycemic control, specifically less time in range and more time below range, was associated with an increased risk for Alzheimer disease.
The scientists weren’t looking for a benefit – in fact, they were running the trial to investigate a concern that Ozempic may be linked to ... associated with a lower risk of nicotine misuse ...
GLP-1 drugs like Ozempic and Wegovy may help reduce risks from severe COVID-19 for people living with overweight or obesity, ...